The Institute for Technology-Inspired Regenerative Medicine (MERLN) at Maastricht University, Netherlands, have announced their partnership with Aspect Biosystems, a tissue engineering and 3D bioprinting company. Through this collaboration, RX1 Bioprinting Platform by Aspect will be placed inside Professor Lorenzo Moroni’s Lab at the university, which then will be used by Dr. Carlos Mota to work towards 3D Printed Kidney Tissue. There, Dr. Carlos Mota, the head of bioprinting research, will put it to good use developing 3D bioprinted kidney tissue.
